ZX008

These Epilepsy Drugmakers Are About to Brawl
Motley Fool
Thu, 07/19/18 - 11:30 pm
epilepsy
Zogenix
ZX008
GW Pharma
Epidiolex
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug
Xconomy
Thu, 07/12/18 - 09:59 am
Dravet syndrome
clinical trials
Zogenix
ZX008
FenPhen
GW Pharma
Epidiolex
3 Biotech Stocks With Major Catalysts Incoming
Motley Fool
Tue, 07/3/18 - 11:04 am
Spark Therapeutics
Zogenix
Progenics Pharmaceuticals
SPK-8011
ZX008
Azedra
FDA
Zogenix wins inside track at FDA with childhood epilepsy ‘breakthrough’
Endpoints
Tue, 02/6/18 - 09:24 am
Zogenix
FDA
epilepsy
Dravet syndrome
ZX008
breakthrough therapies
A Tiny Biotech Just Dealt a Big Blow to Marijuana's Use in Epilepsy
Motley Fool
Mon, 10/2/17 - 11:09 am
biotech
marijuana
epilepsy
ZX008
Zogenix
Epidiolex
GW Pharma
seizures
3 Biotech Stocks That Soared This Week: Are They Buys?
Motley Fool
Mon, 10/2/17 - 09:59 am
biotech
Madrigal Pharmaceuticals
Spectrum Pharmaceuticals
poziotinib
ZX008
Zogenix
3 Biotech Stocks With Big News Coming
Motley Fool
Wed, 08/2/17 - 10:16 am
biotech
Flexion
Zilretta
osteoarthritis of the knee
Zogenix
ZX008
Dravet syndrome
Keryx
chronic kidney disease
Auryxia
3 Beaten-Up Biotechs Bouncing Back in 2017 (Hint: One Is a Marijuana Stock)
Motley Fool
Sun, 07/23/17 - 11:44 am
Zogenix
INSYS Therapeutics
Keryx
ZX008
Syndros
Auryxia
Zogenix delays epilepsy drug trials by three months
Yahoo/Reuters
Tue, 07/14/15 - 10:47 am
clinical trials
epilepsy
Zogenix
ZX008